The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

Takahiro Yamazaki; Jonathan M. Pitt; Marie Vétizou; Aurélien Marabelle; Chrystel Flores; Øystein Rekdal; Guido Guido Kroemer; Laurence Zitvogel

doi:10.1038/cdd.2016.35

Related publications

Article2015

The oncolytic peptide LTX-315 triggers necrotic cell death

Sabrina Forveille, Heng Zhou, Allan Sauvat, Lucillia Bezu, Kévin Müller, Peng Liu, Laurence Zitvogel, Gérard Pierron, Øystein Rekdal, Oliver Kepp, Guido Guido Kroemer

Article2016

The oncolytic peptide LTX-315 triggers immunogenic cell death

Heng Zhou, Sabrina Forveille, Allan Sauvat, Takahiro Yamazaki, Laura Senovilla, Yuting Ma, Peng Liu, Huikang Yang, Lucillia Bezu, Kristen E. Muller, Laurence Zitvogel, Øystein Rekdal, Oliver Kepp, Guido Guido Kroemer

Article2016

Abstract 2326: LTX-315, an oncolytic peptide, increases anticancer immunity mediated by CTLA4 blockade in an interleukin-2 receptor beta-chain-dependent manner

Takahiro Yamazaki, Marie Vétizou, Camila Flores, Aurélien Marabelle, Baldur Sveinbjørnsson, Øystein Rekdal, Guido Guido Kroemer, Laurence Zitvogel

Article2015

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization

Heng Zhou, Sabrina Forveille, Allan Sauvat, Valentina Sica, Valentina Izzo, Sylvère Durand, Kévin Müller, Peng Liu, Laurence Zitvogel, Øystein Rekdal, Oliver Kepp, Guido Guido Kroemer

Article2017

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer, Virginie Nourtier, Xavier Préville, Éric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan M. Pitt, Guido Guido Kroemer, Laurence Zitvogel